title: Preclinical evaluation of carbon-11 and fluorine-18 sulfonamide derivatives for in vivo radiolabeling of erythrocytes.
abstract: BACKGROUND
  To date, few PET tracers for in vivo labeling of red blood cells (RBCs) are available. In this study, we report the radiosynthesis and in vitro and in vivo evaluation of 11C and 18F sulfonamide derivatives targeting carbonic anhydrase II (CA II), a metallo-enzyme expressed in RBCs, as potential blood pool tracers. A proof-of-concept in vivo imaging study was performed to demonstrate the feasibility to assess cardiac function and volumes using electrocardiogram (ECG)-gated positron emission tomography (PET) acquisition in comparison with cine magnetic resonance imaging (cMRI) in rats and a pig model of myocardial infarction.
  
  
  METHODS
  The inhibition constants (Ki) of CA II were determined in vitro for the different compounds by assaying CA-catalyzed CO2 hydration activity. Binding to human RBCs was estimated after in vitro incubation of the compounds with whole blood. Biodistribution studies were performed to evaluate tracer kinetics in NMRI mice. ECG-gated PET acquisition was performed in Wistar rats at rest and during pharmacological stress by infusing dobutamine at 10 μg/kg/min and in a pig model of myocardial infarction. Left ventricular ejection fraction (LVEF) and volumes were compared with values from cMRI.
  
  
  RESULTS
  The Ki of the investigated compounds for human CA II was found to be in the range of 8 to 422 nM. The fraction of radioactivity associated with RBCs was found to be ≥90% at 10- and 60-min incubation of tracers with heparinized human blood at room temperature for all tracers studied. Biodistribution studies in mice indicated that 30% to 67% of the injected dose was retained in the blood pool at 60 min post injection. A rapid and sustained tracer uptake in the heart region with an average standardized uptake value of 2.5 was observed from micro-PET images. The LVEF values obtained after pharmacological stress in rats closely matched between the cMRI and micro-PET values, whereas at rest, a larger variation between LVEF values obtained by both techniques was observed. In the pig model, a good agreement was observed between PET and MRI for quantification of left ventricular volumes and ejection fraction.
  
  
  CONCLUSIONS
  The 11C and 18F sulfonamide derivatives can be used for efficient in vivo radiolabeling of RBCs, and proof-of-concept in vivo imaging studies have shown the feasibility and potential of these novel tracers to assess cardiac function.
authors: Laboratory of Radiopharmacy, Katholieke Universiteit Leuven, O&N2, Herestraat 49, Box 821, Leuven, BE-3000, Belgium. guy.bormans@pharm.kuleuven.be.
authors: Olivier
authors: O
authors: Gheysens
authors: Vamsidhar
authors: V
authors: Akurathi
authors: Rufael
authors: R
authors: Chekol
authors: Tom
authors: T
authors: Dresselaers
authors: Sofie
authors: S
authors: Celen
authors: Michel
authors: M
authors: Koole
authors: Dieter
authors: D
authors: Dauwe
authors: Bernard J
authors: BJ
authors: Cleynhens
authors: Piet
authors: P
authors: Claus
authors: Stefan
authors: S
authors: Janssens
authors: Alfons M
authors: AM
authors: Verbruggen
authors: Johan
authors: J
authors: Nuyts
authors: Uwe
authors: U
authors: Himmelreich
authors: Guy M
authors: GM
authors: Bormans